The Real Winner of TrumpRx

February 7, 2026

TL;DR

TrumpRx, a government initiative, offers discounts on select prescription drugs, aiming to lower prices for Americans.
Most insured Americans will find better deals through their existing insurance plans than through TrumpRx.
Cheaper generic alternatives to some drugs listed on TrumpRx are available through other discount platforms.
Pharmaceutical companies appear to be major beneficiaries, gaining positive PR while retaining high prices on their most lucrative drugs.
Key high-selling drugs like Keytruda and tirzepatide are not included on TrumpRx.
The platform is still developing, with more drugs expected to be added in the future, potentially impacting new drug pricing.
Past promises of drug cost relief from the Trump administration, like discount cards, did not materialize.

Continue reading the original article